Overview

Suprachoroidal Administration in Subjects With Metastases to the Choroid

Status:
RECRUITING
Trial end date:
2027-02-28
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary carcinoma.
Phase:
PHASE2
Details
Lead Sponsor:
Aura Biosciences
Treatments:
Lasers